Innate and adaptive immune responses following PD‐L1 blockade in treating chronic murine alveolar echinococcosis
Résumé
Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) immune checkpoint blockade are efficacious in certain cancer therapies.